Companies:
49,817
Total Market Cap:
139336394597235.87
Global Rank
#29265
Country Rank
#123
Market Cap
53.46 M
Price
3.47
Change (%)
2.79%
Volume
17,200
Biohit Oyj's latest marketcap:
53.46 M
As of 07/05/2025, Biohit Oyj's market capitalization has reached $53.46 M. According to our data, Biohit Oyj is the 29265th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 53.46 M |
| Revenue (ttm) | 16.82 M |
| Net Income (ttm) | 3.02 M |
| Shares Out | 15.19 M |
| EPS (ttm) | 0.2 |
| Forward PE | 19.93 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/06/2025 |
Market Cap Chart
Data Updated: 07/05/2025
Biohit Oyj's yearly market capitalization.
Biohit Oyj has seen its market value drop from €64.6 M to €53.46 M since 2014, representing a total decrease of 17.24% and an annual compound decline rate (CAGR) of 1.78%.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | €53.46 M | 22.74% | 29265 |
| 12/30/2024 | €34.77 M | 22.03% | 30243 |
| 12/29/2023 | €28.49 M | 20.61% | 30858 |
| 12/30/2022 | €23.62 M | -14.44% | 31316 |
| 12/30/2021 | €27.61 M | -26.01% | 30341 |
| 12/30/2020 | €37.31 M | -26.19% | 25255 |
| 12/30/2019 | €50.55 M | 14.22% | 21218 |
| 12/28/2018 | €44.26 M | -21.14% | 20850 |
| 12/29/2017 | €56.12 M | -36.89% | 20042 |
| 12/30/2016 | €88.93 M | 10.47% | 16237 |
Company Profile
About Biohit Oyj
Biohit Oyj is a biotechnology company specializing in the manufacturing and sale of diagnostic products and systems for research institutions, healthcare, and industrial applications worldwide.
Key Product Offerings
- Diagnostic Tests:
- GastroPanel Unified – Comprehensive stomach health check.
- GastroPanel Four-in-One – Advanced stomach test.
- GastroSoft – Software assisting clinicians in diagnostics.
- Biohit Active B12 – Measures total vitamin-B12 serum concentration.
- BIOHIT Total 25OH Vitamin D – Determines vitamin D2 and D3 levels.
- Biohit Calprotectin – Differentiates between inflammatory bowel disease and irritable bowel syndrome.
- Quick Tests:
- GastroPanel Quick Test NT – Detects H. pylori and atrophic gastritis.
- BIOHIT Celiac Quick Test – Diagnoses celiac disease.
- Biohit ColonView Quick Test – Detects fecal occult blood.
- Biohit H. pylori UFT300 & Quick Test – Identifies H. pylori infection.
- Lactose Intolerance Quick Test – Supports lactose intolerance diagnosis.
- Acetaldehyde-Binding Products:
- Acetium Capsules – For low-acid stomach and chronic H. pylori infection.
- Acetium Lozenges – Aids in smoking cessation.
- Monoclonal Antibodies: Used in cellular pathology, neurobiology, oncology, and gastric biomarker research.
- Biohit Faex: Stool sample collection and processing solution.
Company Background
Founded in 1988, Biohit Oyj is headquartered in Helsinki, Finland, and continues to innovate in biotechnology and diagnostic solutions.
Frequently Asked Questions
-
What is Biohit Oyj's (HEL-BIOBV) current market cap?As of 07/05/2025, Biohit Oyj (including the parent company, if applicable) has an estimated market capitalization of $53.46 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Biohit Oyj (HEL-BIOBV) rank globally by market cap?Biohit Oyj global market capitalization ranking is approximately 29265 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.